These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32614073)

  • 1. A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
    Odi R; Bibi D; Wager T; Bialer M
    Epilepsia; 2020 Aug; 61(8):1543-1552. PubMed ID: 32614073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
    Golfar Y; Shayanfar A
    J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
    Charalabidis A; Sfouni M; Bergström C; Macheras P
    Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class.
    Box KJ; Comer JE
    Curr Drug Metab; 2008 Nov; 9(9):869-78. PubMed ID: 18991583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDDCS applied to over 900 drugs.
    Benet LZ; Broccatelli F; Oprea TI
    AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization.
    Ghose AK; Ott GR; Hudkins RL
    ACS Chem Neurosci; 2017 Jan; 8(1):147-154. PubMed ID: 27741392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the molecular properties and metabolism of top prescribed drugs.
    Zhong HA; Mashinson V; Woolman TA; Zha M
    Curr Top Med Chem; 2013; 13(11):1290-307. PubMed ID: 23675936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.
    Wolk O; Agbaria R; Dahan A
    Drug Des Devel Ther; 2014; 8():1563-75. PubMed ID: 25284986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2016 Jun; 7(6):767-75. PubMed ID: 26991242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
    Bocci G; Oprea TI; Benet LZ
    AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
    Li J; Larregieu CA; Benet LZ
    Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
    Cao X; Li H; Wang M; Ren X; Deng Y
    Biomed Chromatogr; 2020 Feb; 34(2):e4757. PubMed ID: 31755125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties.
    Oriyama T; Yamamoto T; Nara K; Kawano Y; Nakajima K; Suzuki H; Aoyama T
    J Pharm Health Care Sci; 2020 Nov; 6(1):23. PubMed ID: 33292621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
    Hosey CM; Chan R; Benet LZ
    AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDDCS, the Rule of 5 and drugability.
    Benet LZ; Hosey CM; Ursu O; Oprea TI
    Adv Drug Deliv Rev; 2016 Jun; 101():89-98. PubMed ID: 27182629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.